Lilly to build $2.5 billion Germany plant as obesity drug demand soars

DealsHealth

Reuters exclusively reported^[1] that Eli Lilly (LLY.N) will build its first plant in Germany in the western town of Alzey for 2.3 billion euros ($2.5 billion), the U.S. drugmaker said on Friday, as the sector scrambles to meet soaring demand for

Read more https://www.reutersagency.com/en/reutersbest/article/lilly-to-build-2-5-billion-germany-plant-as-obesity-drug-demand-soars/